Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Looking Past the Balance Sheet When Valuing Device Company IPOs

This article was originally published in Start Up

Executive Summary

Biotech companies have an intuitively direct relationship between the amount of cash on their balance sheets and their IPO valuations. But medical device companies are different beasts altogether.
Advertisement

Related Content

Do Healthy Balance Sheets Boost Biotech IPO Valuations?
Do Healthy Balance Sheets Boost Biotech IPO Valuations?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel